ResearcherShandong UniversityActive in the last 2 years
Dexin Yu
Matched on ORCID iD 0000-0002-3430-4817; OpenAlex author ID A5039420381. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 0, last author 9)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 5 papers
Papers 9
- Evaluation of Occult Liver Metastases in Pancreatic Adenocarcinoma by Diffusion-Weighted Related Magnetic Resonance Imaging. Last author DOI 10.1002/jmri.29747↗
- Exploring the value of multiparametric quantitative MRI in the assessment of pancreatic ductal adenocarcinoma fibrosis grading. Last author DOI 10.1007/s00330-024-11246-w↗
- CT-based radiomics models decode fibrosis content and molecular differences in pancreatic ductal adenocarcinoma: a multi-institutional study. Last author DOI 10.1186/s13244-025-02036-z↗
- HIF-1α expression is associated with the pathological response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma patients and can be predicted us… Last author DOI 10.21037/qims-24-103↗
- Nanotension Relief Agent Enhances Tissue Penetration by Reducing Solid Stress in Pancreatic Ductal Adenocarcinoma via Rho/ROCK Pathway Inhibition. Last author DOI 10.34133/bmr.0173↗
- nc-RNA-mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer. Last author DOI 10.1002/cam4.5260↗
- The value of enhanced CT features and texture-signatures in assessing the inflammatory infiltration of pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fonc.2023.1078861↗
- Synergistic ferroptosis-gemcitabine chemotherapy of the gemcitabine loaded carbonaceous nanozymes to enhance the treatment and magnetic resonance imaging monit… Last author DOI 10.1016/j.actbio.2022.02.006↗
- Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenoc… Last author DOI 10.3389/fonc.2022.1037672↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Fangqing Wang · 6 shared papers, 2022–2025 · strength 1.58
- Paper Evaluation of Occult Liver Metastases in Pancreatic Adenocarcinoma by Diffusion-Weighted Related Magnetic Resonance Ima… DOI 10.1002/jmri.29747↗
- Paper Exploring the value of multiparametric quantitative MRI in the assessment of pancreatic ductal adenocarcinoma fibrosis … DOI 10.1007/s00330-024-11246-w↗
- Paper CT-based radiomics models decode fibrosis content and molecular differences in pancreatic ductal adenocarcinoma: a mult… DOI 10.1186/s13244-025-02036-z↗
- Jianwei Xu · 5 shared papers, 2022–2025 · strength 1.29
- Paper Evaluation of Occult Liver Metastases in Pancreatic Adenocarcinoma by Diffusion-Weighted Related Magnetic Resonance Ima… DOI 10.1002/jmri.29747↗
- Paper Exploring the value of multiparametric quantitative MRI in the assessment of pancreatic ductal adenocarcinoma fibrosis … DOI 10.1007/s00330-024-11246-w↗
- Paper CT-based radiomics models decode fibrosis content and molecular differences in pancreatic ductal adenocarcinoma: a mult… DOI 10.1186/s13244-025-02036-z↗
- Yuxuan Zhao · 2 shared papers, 2023–2025 · strength 0.46
- Gaorui Zhang · 2 shared papers, 2022–2025 · strength 0.43
- Paper Nanotension Relief Agent Enhances Tissue Penetration by Reducing Solid Stress in Pancreatic Ductal Adenocarcinoma via R… DOI 10.34133/bmr.0173↗
- Paper Synergistic ferroptosis-gemcitabine chemotherapy of the gemcitabine loaded carbonaceous nanozymes to enhance the treatm… DOI 10.1016/j.actbio.2022.02.006↗
- Hui Zhang · 1 shared paper, 2025 · strength 0.28
- Lei Wang · 1 shared paper, 2025 · strength 0.28
- Feiran Yu · 1 shared paper, 2025 · strength 0.25
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.